Velikova, Galina, Morden, James P, Haviland, Joanne S, Emery, Charlotte, Barrett-Lee, Peter, Earl, Helena, Bloomfield, David, Brunt, Adrian Murray, Canney, Peter, Coleman, Robert, Verrill, Mark, Wardley, Andrew, Bertelli, Gianfilippo, Ellis, Paul, Stein, Rob, Bliss, Judith M, Cameron, David, "Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.", The Lancet. Oncology,